Analysis for PFE
- 📈 Growth — 4/30
- 💰 Profitability — 16/20
- 🏦 Financial Health — 18/20
- 💵 Valuation — 14/20
- ⚠️ Risk — 7/10
Summary:
📈 Growth & Financial Trajectory
Revenues started at 17.70B in 2024 Q3 and ended at 15.03B in 2026 Q2, a roughly -15% decline. Net Income moved from a solid +4.47B to a small loss of about -0.24B, with a peak in 2025 Q3 (+3.55B) and losses in 2025 Q4 through 2026 Q2. The pattern shows revenue stability but waning earnings power, culminating in a weaker bottom line as of 2026. Overall, the trajectory suggests modest top-line resilience but increasing earnings risk should revenue stay pressured.
💰 Margins & Cash Flow
- Gross margins remained high, roughly in the 70%–80% range across eight quarters (e.g., 70.3% in 2024 Q3/Q4; ~79% in 2025 Q1; ~72–75% thereafter), indicating strong product profitability.
- Operating income was positive in most periods but swung negative in 2025 Q4 and 2026 Q2, signaling evolving cost dynamics and operating leverage shifts.
- Cash flow: operating cash flow was generally positive, while investing activities were cash outflows (typical capex/investing), yielding mixed to modestly negative overall cash flow in some quarters.
🛡️ Balance Sheet & Liquidity
Total assets run ~206–208B with liabilities ~115–126B and equity ~85–90B, producing a solid balance of assets vs liabilities. Current assets and current liabilities are roughly aligned in the latest periods, producing a near-1.0 current ratio. The balance sheet shows substantial liquidity headroom and a durable equity base, supporting resilience through earnings volatility.
⚠️ Key Drivers & Risks
- Drivers: Strong gross margins across quarters; robust cash flow generation.
- Risks: Earnings volatility due to quarterly mix and recent losses; sensitivity to product pipeline and regulatory/patent dynamics.